Home › Cancro pancreatico › Indiana › Indianapolis
Studi clinici su Cancro pancreatico a Indianapolis, IN
9 studi su Cancro pancreatico cercano partecipanti presso sedi a Indianapolis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- IU Simon Cancer Center, Indianapolis
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
In reclutamentoFase 3
- Community Health Network, Indianapolis
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
In reclutamentoFase 3
- Investigative Site US021, Indianapolis
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
In reclutamentoFase 3
- Indiana University Health - Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Community Health Network, Indianapolis
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
In reclutamentoStudio osservazionale
- Riley Hospital for Children, Indianapolis
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
In reclutamentoStudio osservazionale
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- Community Health Network, Inc. /ID# 243011, Indianapolis
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
In reclutamentoFase 2
- Ohio State University-Telemedicine, Indianapolis
Studi su Cancro pancreatico in altre città
- Houston, TX61 studi
- New York City, NY60 studi
- Boston, MA43 studi
- Nashville, TN39 studi
- Los Angeles, CA35 studi
- St. Louis, MO33 studi
- Arlington, VA33 studi
- Baltimore, MD31 studi
- San Antonio, TX31 studi
- Philadelphia, PA26 studi
- Tampa, FL26 studi
- Durham, NC24 studi
Altri studi a Indianapolis
- Cancro del polmone non a piccole cellule32 studi
- Cancro (tutti i tipi)24 studi
- Insufficienza cardiaca23 studi
- Obesità20 studi
- Cancro al seno20 studi
- Cancro metastatico19 studi
- Cancro colorettale18 studi
- Cancro ovarico17 studi
- Malattie cardiovascolari17 studi
- Cancro ai polmoni16 studi
- Diabete di tipo 114 studi
- Cancro dell'endometrio14 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.